(A) Treatment of differentiated C2C12 myotubes with the proteasome inhibitor MG132 rescues TBP protein levels. Western blot analysis of cytoplasmic and nuclear extracts from C2C12 myoblasts and …
Western blot analysis of whole-cell extracts prepared from C2C12 myoblasts (D0) and myotubes collected on day 3 (D3) and day 6 (D6) post-differentiation was done using antibodies against TAF4, TBP, …
(A) In vitro ubiquitination of TBP by HeLa cell lysates. In vitro transcribed and translated HA-TBP was incubated with indicated HeLa cellular fractions for ubiquitination assays. After the …
(A) GST-TBP but not GST is ubiquitinated by HeLa S100 cytoplasmic fraction in vitro. Recombinant GST-TBP and GST proteins (right) were incubated with Hela S100 fraction for in vitro ubiquitination …
(A) Recombinant Huwe1 protein ubiquitinates TBP in vitro. Titrations (twofold concentration range) of recombinant His-tag Huwe1 protein are incubated with GST-TBP supplemented with E1, UbcH5b, …
(A) PageBlue SDS-PAGE Gel of purified recombinant wild-type (WT), catalytic domain truncation (ΔC) and catalytic site C4341S mutant (C → S) Huwe1 proteins are shown. HiMark pre-stained protein …
GST-tagged full length (FL) TBP, TBP C-terminal DNA binding domain (DBD) and N-terminal transactivation domain (TAD) were used to pull-down purified recombinant Huwe1 protein. Pull down materials …
(A) Huwe1 knockdown increases TBP protein levels in 293T cells. Western blot analysis of whole cell extracts from control (NT) and Huwe1 knockdown 293T cells was done using antibodies against Huwe1 …
(A) Schematic representation of the principle for fluorescent timer assay. (B) Fluorescent-timer TBP fusion protein exhibits higher mCherry/GFP ratio in Huwe1 knockdown 293T cells. 293T cells were …
(A) Lentivirus-mediated depletion of Huwe1 elevates TBP protein level in C2C12 myotubes. Cytoplasmic and nuclear extracts of C2C12 myoblasts infected with control (NT) lentiviruses or two different …
(A) Control and Huwe1 knockdown C2C12 myoblasts were treated with 50 μg/ml cycloheximide. Cells were collected at indicated time points and analyzed by western blot using anti-TBP and anti-Tubulin …
(A) Huwe1 knockdown impaired C2C12 differentiation efficiency. Shown are phase contrast images of control and Huwe1 knockdown C2C12 myoblasts after 6 days of differentiation in 2% horse serum. (B) …
Differentiation gene expression analysis of control and Huwe1 knockdown C2C12 cells on differentiation Day 6 by RNA-seq.
Differentiation gene expression analysis of control and Huwe1 knockdown myotubes on differentiation Day 8 by RNA-seq.
Differentiation gene expression analysis of control and Huwe1 knockdown C2C12 cells on differentiation Day 0 by RNA-seq.
(A) Huwe1 knockdown C2C12 myoblasts did not exhibit significant morphological differences compared to control C2C12 s when cultured in proliferation medium (10% FBS). (B) Huwe1 knockdown results in …
(A) Huwe1, Myod1 and Mef2c mRNA levels in control and two different Huwe1 knockdown C2C12 myoblast lines were analyzed by RT-qPCR and normalized to Gapdh. Shown are values relative to control cells …
(A) USP10 overexpression inhibits TBP ubiquitination in vivo. 293T cells were transfected with indicated plasmids as well as a plasmid expressing HA-TBP. Ubiquitin conjugates were purified using …
(A) USP10 overexpression increases TBP protein level. Wild type and USP10 overexpressing C2C12 (stable cell line) were double-stained using rabbit anti-USP10 and mouse anti-TBP primary antibodies, …
(A) USP10 overexpressing C2C12 myoblasts were treated with 50 μg/ml cycloheximide. Cells were collected at indicated time points and analyzed by western blot using anti-TBP and anti-Tubulin …
Both Huwe1 E3 ligase and USP10 deubiquitinase are present in proliferating myoblasts to maintain steady state TBP protein levels. Upon stimulation by differentiation signals, Huwe1 protein levels …